Abstract
Purpose
To examine factors influencing primary care provider (PCP) adoption of CT colonography (CTC) for colorectal cancer (CRC) screening.
Materials and methods
We performed a retrospective cohort study linking electronic health record (EHR) data with PCP survey data. Patients were eligible for inclusion if they were not up-to-date with CRC screening and if they had CTC insurance coverage in the year prior to survey administration. PCPs were included if they had at least one eligible patient in their panel and completed the survey (final sample N = 95 PCPs; N = 6245 patients). Survey data included perceptions of CRC screening by any method, as well as CTC specifically. Multivariate logistic regression estimated odds ratios and 95% confidence intervals for PCP and clinic predictors of CRC screening by any method and screening with CTC.
Results
Substantial variation in CTC use was seen among PCPs and clinics (range 0–16% of CRC screening). Predictors of higher CTC use were PCP perceptions that CTC is effective in reducing CRC mortality, higher number of perceived advantages to screening with CTC, and Internal Medicine specialty. Factors not associated with CTC use were PCP perceptions of less organizational capacity to meet demand for colonoscopy, number of perceived disadvantages to screening with CTC, PCP age and gender, and clinic factors.
Conclusion
Significant variation in PCP adoption of CTC exists. PCP perceptions of CTC and specialty practice were related to CTC adoption. Strategies to increase PCP adoption of CTC for CRC screening should include emphasis on the effectiveness and advantages of CTC.
Similar content being viewed by others
References
Zauber AG, Winawer SJ, O’Brien MJ, et al. (2012) Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths. N Engl J Med 366:687–696. doi:10.1056/NEJMoa1100370
Nishihara R, Wu K, Lochhead P, et al. (2013) Long-term colorectal-cancer incidence and mortality after lower endoscopy. N Engl J Med 369:1095–1105. doi:10.1056/NEJMoa1301969
Lin JS, Piper MA, Perdue LA, et al. (2016) Screening for colorectal cancer: updated evidence report and systematic review for the US Preventive Services Task Force. JAMA 315:2576–2594. doi:10.1001/jama.2016.3332
Siegel RL, Miller KD, Jemal A (2016) Cancer statistics, 2016. CA 66:7–30. doi:10.3322/caac.21332
Centers for Disease Control and Prevention (CDC) (2008) Use of colorectal cancer tests—United States, 2002, 2004, and 2006. MMWR Morb Mortal Wkly Rep 57:253–258
The White House Cancer Moonshot Task Force (2016) Report of the Cancer Moonshot Task Force. https://www.whitehouse.gov/CancerMoonshot. Accessed October 19 2016
Inadomi JM, Vijan S, Janz NK, et al. (2012) Adherence to colorectal cancer screening: a randomized clinical trial of competing strategies. Arch Intern Med 172:575–582. doi:10.1001/archinternmed.2012.332
DeBourcy AC, Lichtenberger S, Felton S, et al. (2008) Community-based preferences for stool cards versus colonoscopy in colorectal cancer screening. J Gen Intern Med 23:169–174. doi:10.1007/s11606-007-0480-1
Wong MCS, Ching JYL, Chan VCW, et al. (2014) Informed choice vs. no choice in colorectal cancer screening tests: a prospective cohort study in real-life screening practice. Am J Gastroenterol 109:1072–1079. doi:10.1038/ajg.2014.136
Bibbins-Domingo K, Grossman DC, Curry SJ, et al. (2016) Screening for colorectal cancer: US Preventive Services Task Force recommendation statement. JAMA 315:2564–2575. doi:10.1001/jama.2016.5989
Johnson CD, Chen MH, Toledano AY, et al. (2008) Accuracy of CT colonography for detection of large adenomas and cancers. N Engl J Med 359:1207–1217. doi:10.1056/NEJMoa0800996
Kim DH, Pickhardt PJ, Taylor AJ, et al. (2007) CT colonography versus colonoscopy for the detection of advanced neoplasia. N Engl J Med 357:1403–1412. doi:10.1056/NEJMoa070543
Pickhardt PJ, Choi JR, Hwang I, et al. (2003) Computed tomographic virtual colonoscopy to screen for colorectal neoplasia in asymptomatic adults. N Engl J Med 349:2191–2200. doi:10.1056/NEJMoa031618
Levin B, Lieberman DA, McFarland B, et al. (2008) Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: A joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. CA 58:130–160. doi:10.3322/CA.2007.0018
Pickhardt PJ, Taylor AJ, Kim DH, et al. (2006) Screening for colorectal neoplasia with CT colonography: initial experience from the 1st year of coverage by third-party payers. Radiology 241:417–425. doi:10.1148/radiol.2412052007
Weiss JM, Smith MA, Pickhardt PJ, et al. (2013) Predictors of colorectal cancer screening variation among primary-care providers and clinics. Am J Gastroenterol 108:1159–1167. doi:10.1038/ajg.2013.127
Klabunde CN, Frame PS, Meadow A, et al. (2003) A national survey of primary care physicians’ colorectal cancer screening recommendations and practices. Prev Med 36:352–362
Klabunde CN, Vernon SW, Nadel MR, et al. (2005) Barriers to colorectal cancer screening: a comparison of reports from primary care physicians and average-risk adults. Med Care 43:939–944
Mysliwiec PA, Brown ML, Klabunde CN, et al. (2004) Are physicians doing too much colonoscopy? A national survey of colorectal surveillance after polypectomy. Ann Intern Med 141:264–271
Nadel MR, Shapiro JA, Kiabunde CN, et al. (2005) A national survey of primary care physicians’ methods for screening for fecal occult blood. Ann Intern Med 142:86–94
WCHQ Wisconsin Collaborative for Healthcare Quality. http://www.wchq.org/measures/sources.php. Accessed October 19 2016
Sheehy AM, Flood GE, Tuan WJ, et al. (2010) Analysis of guidelines for screening diabetes mellitus in an ambulatory population. Mayo Clin Proc 85:27–35. doi:10.4065/mcp.2009.0289
Pham HH, Schrag D, O’Malley AS, et al. (2007) Care patterns in Medicare and their implications for pay for performance. N Engl J Med 356:1130–1139. doi:10.1056/NEJMsa063979
Maldonado G, Greenland S (1993) Interpreting model coefficients when the true model form is unknown. Epidemiology 4:310–318
Akaike H (1974) A new look at the statistical model identification. IEEE Trans Autom Control AC 19:716–723
United States Preventive Services Task Force (2007) Guide to Clinical Preventive Services. Agency for Healthcare Research and Quality: Rockville
Pickhardt PJ (2015) CT colonography for population screening: ready for prime time? Dig Dis Sci 60:647–659. doi:10.1007/s10620-014-3454-2
Pickhardt PJ, Hanson ME, Vanness DJ, et al. (2008) Unsuspected extracolonic findings at screening CT colonography: clinical and economic impact. Radiology 249:151–159. doi:10.1148/radiol.2491072148
Yee J, Kumar NN, Godara S, et al. (2005) Extracolonic abnormalities discovered incidentally at CT colonography in a male population. Radiology 236:519–526. doi:10.1148/radiol.2362040166
Zalis ME, Blake MA, Cai W, et al. (2012) Diagnostic accuracy of laxative-free computed tomographic colonography for detection of adenomatous polyps in asymptomatic adults: a prospective evaluation. Ann Intern Med 156:692–702. doi:10.7326/0003-4819-156-10-201205150-00005
Behrens C, Stevenson G, Eddy R, et al. (2010) The benefits of computed tomographic colonography in reducing a long colonoscopy waiting list. Can Assoc Radiol J 61:33–40. doi:10.1016/j.carj.2009.09.003
Gluecker TM, Johnson CD, Wilson LA, et al. (2003) Extracolonic findings at CT colonography: evaluation of prevalence and cost in a screening population. Gastroenterology 124:911–916. doi:10.1053/gast.2003.50158
Pooler BD, Kim DH, Pickhardt PJ (2016) Potentially important extracolonic findings at screening CT colonography: Incidence and outcomes data from a clinical screening program. Am J Roentgenol 206:313–318. doi:10.2214/AJR.15.15193
Veerappan GR, Ally MR, Choi JH, et al. (2010) Extracolonic findings on CT colonography increases yield of colorectal cancer screening. Am J Roentgenol 195:677–686. doi:10.2214/AJR.09.3779
Park SK, Park DI, Lee SY, et al. (2009) Extracolonic findings of computed tomographic colonography in Koreans. World J Gastroenterol 15:1487–1492
Fichman RG, Kemerer CF (1993) Adoption of software engineering process innovations—the case of object orientation. Sloan Manag Rev 34:7–22
Pickhardt PJ, Hassan C, Halligan S, et al. (2011) Colorectal cancer: CT colonography and colonoscopy for detection–systematic review and meta-analysis. Radiology 259:393–405. doi:10.1148/radiol.11101887
Kim DH, Matkowskyj KA, Lubner MG, et al. (2016) Serrated polyps at CT colonography: prevalence and characteristics of the serrated polyp spectrum. Radiology 280(2):455–463. doi:10.1148/radiol.2016151608
Crosson FJ (2005) The delivery system matters. Health Aff (Millwood) 24(6):1543–1548. doi:10.1377/hlthaff.24.6.1543
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Funding
This work was supported by the National Cancer Institute (Grants R01 CA144835 and P30 CA014520); the National Center for Advancing Translational Sciences (Grant UL1TR000427); the American Cancer Society (Grant MRSG-13-144-01-CPHPS); and the UW Health Innovation Program.
Conflict of interest
Perry J. Pickhardt is co-founder of VirtuoCTC and shareholder in SHINE, Elucent, and Cellectar Biosciences. David H. Kim is co-founder of VirtuoCTC, consultant for Viatronix, on the Medical Advisory Board for Digital ArtForms, and shareholder in Cellectar and Elucent. Patrick R. Pfau serves on the Scientific Advisory Board of Exact Sciences. The other authors declare that they have no conflict of interest.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. For this type of study formal consent is not required.
Informed consent
Statement of informed consent was not applicable since the manuscript does not contain any patient data.
Rights and permissions
About this article
Cite this article
Weiss, J.M., Kim, D.H., Smith, M.A. et al. Predictors of primary care provider adoption of CT colonography for colorectal cancer screening. Abdom Radiol 42, 1268–1275 (2017). https://doi.org/10.1007/s00261-016-0971-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00261-016-0971-9